Evaluation of Perspective and Coplanar Cockpit Displays of Traffic Information to Support Hazard Awareness in Free Flight

We examined the cockpit display representation of traffic, to support the pilot in tactical planning and conflict avoidance. Such displays may support the "free flight" concept, but can also support greater situation awareness in a non-free flight environment. Two perspective views and a coplanar display were contrasted in scenarios in which pilots needed to navigate around conflicting traffic, either in the absence (low workload) or presence (high workload) of a second intruder aircraft. All three formats were configured with predictive aiding vectors that explicitly represented the predicted point of closest pass, and predicted penetration of an alert zone around ownship. Ten pilots were assigned to each of the display conditions, and each flew a series of 60 conflict maneuvers that varied in their workload and the complexity of the conflict geometry. Results indicated a tendency to choose vertical over lateral maneuvers, a tendency which was amplified with the coplanar display. Vertical maneuvers by the intruder produced an added source of workload. Importantly, the coplanar display supported performance in all measures that was equal to or greater than either of the perspective displays (i.e., fewer predicted and actual conflicts, less extreme maneuvers). Previous studies that have indicated perspective superiority have only contrasted these with UNIplanar displays rather than the coplanar display used here

Effects of Antipsychotic Medication on Psychiatric Service Utilization and Cost

Background: Based on randomized clinical trials, consensus has been emerging that the first line of treatment for individuals with psychotic disorders should be the newer atypical or second generation antipsychotic medications rather than the older neuroleptics. Given that acquisition costs of atypical antipsychotics are generally higher than typical antipsychotics, uncertainty exists whether the newer atypicals are cost effective alternatives when used in ordinary practice settings. Aims of the Study: The introduction of newer atypical antipsychotic agents has prompted evaluation of their overall effectiveness in reducing health care costs given their higher acquisition costs. This paper focuses on the effects of differing classes of atypical versus typical antipsychotic medications on psychiatric service utilization and cost for persons with serious mental illness treated in usual practice settings. Methods: Descriptive statistics are used to compare patient characteristics, service rates and costs across psychotropic medication groups. Prediction equations employing ordinary least squares regression models are used to explain variation in cost due to pharmacy group membership controlling for demographics, clinical diagnoses and symptoms. Subjects were 338 Medicaid clients with serious mental illness from Florida, Pennsylvania and Oregon treated in ordinary clinical settings. Resource utilization and costs were operationalized using administrative databases to measure consumption of treatment services and pharmaceuticals for a six month period. Results: Inpatient service use was significantly higher for individuals on atypical only and combination atypical/typical medications compared to those on typical medications only, Background: Based on randomized clinical trials, consensus has been emerging that the first line of treatment for individuals with psychotic disorders should be the newer atypical or second generation antipsychotic medications rather than the older neuroleptics. Given that acquisition costs of atypical antipsychotics are generally higher than typical antipsychotics, uncertainty exists whether the newer atypicals are cost effective alternatives when used in ordinary practice settings. Aims of the Study: The introduction of newer atypical antipsychotic agents has prompted evaluation of their overall effectiveness in reducing health care costs given their higher acquisition costs. This paper focuses on the effects of differing classes of atypical versus typical antipsychotic medications on psychiatric service utilization and cost for persons with serious mental illness treated in usual practice settings. Methods: Descriptive statistics are used to compare patient characteristics, service rates and costs across psychotropic medication groups. Prediction equations employing ordinary least squares regression models are used to explain variation in cost due to pharmacy group membership controlling for demographics, clinical diagnoses and symptoms. Subjects were 338 Medicaid clients with serious mental illness from Florida, Pennsylvania and Oregon treated in ordinary clinical settings. Resource utilization and costs were operationalized using administrative databases to measure consumption of treatment services and pharmaceuticals for a six month period. Results: Inpatient service use was significantly higher for individuals on atypical only and combination atypical/typical medications compared to those on typical medications only, Background: Based on randomized clinical trials, consensus has been emerging that the first line of treatment for individuals with psychotic disorders should be the newer atypical or second generation antipsychotic medications rather than the older neuroleptics. Given that acquisition costs of atypical antipsychotics are generally higher than typical antipsychotics, uncertainty exists whether the newer atypicals are cost effective alternatives when used in ordinary practice settings. Aims of the Study: The introduction of newer atypical antipsychotic agents has prompted evaluation of their overall effectiveness in reducing health care costs given their higher acquisition costs. This paper focuses on the effects of differing classes of atypical versus typical antipsychotic medications on psychiatric service utilization and cost for persons with serious mental illness treated in usual practice settings. Methods: Descriptive statistics are used to compare patient characteristics, service rates and costs across psychotropic medication groups. Prediction equations employing ordinary least squares regression models are used to explain variation in cost due to pharmacy group membership controlling for demographics, clinical diagnoses and symptoms. Subjects were 338 Medicaid clients with serious mental illness from Florida, Pennsylvania and Oregon treated in ordinary clinical settings. Resource utilization and costs were operationalized using administrative databases to measure consumption of treatment services and pharmaceuticals for a six month period. Results: Inpatient service use was significantly higher for individuals on atypical only and combination atypical/typical medications compared to those on typical medications only,whereas outpatient use was highest for those on typicals. Furthermore, six-month costs for both pharmacy and psychiatric services were significantly greater for persons in the atypical only ($6528) and combination typical/atypical groups ($6589) compared to those on typicals only ($3463). There were still significantly higher costs associated with atypical only and the combination typical/atypical users after multivariate controls were used. Discussion: This study showed that Medicaid clients in community settings using atypical only and typical/atypical combination medications had the highest costs both in pharmacy and service use when compared to those on typical only medications. However, this study design does not allow us to ascribe a causal relationship between medication group and service costs. Given that olanzapine was the most recent medication in the compendium of available drugs at the time of this study, it is possible that those in the olanzapine only group were failing on other drugs. Caution must be used in drawing policy implications regarding cost effectiveness of newer medications since individuals who are getting the newer atypical or combination medications in community mental health center settings may be unstable on the older medications. Implications for Future Research: A longer follow-up period is needed to determine if the cohort remaining on current atypical medications stabilize over time while those taking the newest drug on the market become the most costly population

Business on trial: The tobacco securities trust and the 1935 pepper debacle

The prosecution and imprisonment of Lord Kylsant in 1931, following the collapse of the Royal Mail Shipping Group, has long been acknowledged as a landmark event in the history of financial accounting. Far less attention has been given to the equally high profile conviction and imprisonment of three businessmen four years later in the wake of the notorious pepper scandal. This article examines the background to the scandal, particularly the role played by an investment vehicle called the Tobacco Securities Trust, and compares the subsequent trial and conviction to that of the Royal Mail case. The findings of the article serve to endorse studies by accounting historians arguing that Britain's legal environment played a critical role in promoting improvements in the financial disclosure policies evidenced amongst leading British companies during the second quarter of the twentieth century.Financial Disclosure, Primary Commodities, Tin, Shellac, Pepper, Commodity Restriction Schemes, Company Prospectus, Official Receiver, Bankruptcy, Foreign Investments, Royal Mail Case (1931), Boots Pure Drug Co,

Understanding the complexity of catch and release in recreational fishing: an integrative synthesis of global knowledge from historical, ethical social and biological perspectives

Most research on catch-and-release (C&R) in recreational fishing has been conducted from a disciplinary angle focusing on the biological sciences and the study of hooking mortality after release. This hampers understanding of the complex and multifaceted nature of C&R. In the present synopsis, we develop an integrative perspective on C&R by drawing on historical, philosophical, socio-psychological, biological, and managerial insights and perspectives. Such a perspective is helpful for a variety of reasons, such as 1) improving the science supporting successful fisheries management and conservation, 2) facilitating dialogue between managers, anglers, and other stakeholders, 3) minimizing conflict potentials, and 4) paving the path toward sustainable recreational fisheries management. The present work highlights the array of cultural, institutional, psychological, and biological factors and dimensions involved in C&R. Progress toward successful treatment of C&R might be enhanced by acknowledging the complexity inherent in C&R recreational fishing